[{"command":"settings","settings":{"basePath":"\/","pathPrefix":"","ajaxPageState":{"theme":"bvp_2015","theme_token":"U8YqXAJsWylIs1opbA_FE9a6w7-3va2B82tGZu-9PcA"}},"merge":true},{"command":"modal_display","title":"Healthcare","output":"\n\u003Cdiv class=\u0022field field-name-body field-type-text-with-summary field-label-hidden\u0022\u003E\n\n \n \u003Cdiv class=\u0022field-items\u0022\u003E\n\n \n \u003Cdiv class=\u0022field-item even\u0022 property=\u0022content:encoded\u0022\u003E\u003Cp style=\u0022text-align:center\u0022\u003E\u003Ca href=\u0022http:\/\/www.bvp.com\/healthcare\/valuescape\u0022 target=\u0022_blank\u0022\u003E\u003Cimg alt=\u0022\u0022 src=\u0022\/sites\/default\/files\/BVP-HealthcareValuescape.jpg\u0022 style=\u0022width:800px; height:955px\u0022 \/\u003E\u003C\/a\u003E\u003C\/p\u003E\n\u003Cp style=\u0022text-align:left\u0022\u003EBVP\u0027s healthcare team has a diversity of industry experience and is currently looking for investment opportunities in the following areas:\u003C\/p\u003E\n\u003Cul\u003E\u003Cli style=\u0022text-align:left\u0022\u003EHealthcare Services - BVP\u2019s investments in this area include such service providers as VistaCare (NASDAQ:VSTA), the operator of hospice services; U.S. Behavioral Health Services (acquired by Travelers, NYSE:TRV), a provider of outsourced mental health services; IPC The Hospitalist Company (NASDAQ:IPCM), which supplies professionals for in-patient care; and TravCorps (NASDAQ:CCRN), a medical-staffing service.\u003Cbr \/\u003E\u00a0\u003C\/li\u003E\n\u003Cli style=\u0022text-align:left\u0022\u003EHealthcare Information Technology - BVP has invested in companies like Allscripts (NASDAQ:MDRX), whose software automates routine medical-information gathering tasks; GMIS (NASDAQ:GMIS), which developed technology to automate medical insurance claims; and Netsmart Technologies (acquired by Genstar Capital), which is the leading software provider to mental- and behavioral-health facilities.\u003Cbr \/\u003E\u00a0\u003C\/li\u003E\n\u003Cli style=\u0022text-align:left\u0022\u003ETherapeutics - BVP has a long history of backing successful biotech and pharma companies, including Affymax (NASDAQ:AFFY), a developer of novel drugs to address kidney disease and cancer; Isis (NASDAQ:ISIS), creator of a new class of drugs; Sirtris (NASDAQ:SIRT), acquired by GlaxoSmithKline (NYSE:GSK), which has worked extensively with the helpful enzymes known as sirtuins; and Enzytech (acquired by Alkermes (NASDAQ:ALKS), developer of methods to deliver smaller doses of drugs directly to affected body sites.\u003Cbr \/\u003E\u00a0\u003C\/li\u003E\n\u003Cli style=\u0022text-align:left\u0022\u003EDiagnostics \u2013 A relatively new area of focus for BVP\u2019s healthcare practice is the diagnostics sector. BVP believes that new advances in molecular biology and biomedical engineering make the potential \u201cpersonalization of medicine\u201d now possible. To this end, we are actively looking to invest in both content and technology platforms that deliver on this vision in an economical way for our healthcare system.\u003C\/li\u003E\n\u003C\/ul\u003E\u003C\/div\u003E\n\n \n \u003C\/div\u003E\n\n\u003C\/div\u003E"}]